How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: A critical evaluation and a proposal for modifications

Annual Review of Clinical Psychology

Volumn 10, Issue , 2014, Pages 339-367

  Rief, Winfried ^a   Martin, Alexandra ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

Hypochondriasis; Illness anxiety disorder; Medically unexplained symptoms; Pain disorder; Somatic symptom disorder; Somatization; Somatoform disorder

Indexed keywords

ANXIETY; CLINICAL PRACTICE; DISEASE CLASSIFICATION; DSM-5; DSM-IV; HUMAN; HYPOCHONDRIASIS; REVIEW; SOMATIC SYMPTOM DISORDER; SOMATOFORM DISORDER; SYMPTOM;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; REPRODUCIBILITY OF RESULTS; SOMATOFORM DISORDERS;

EID: 84888221435     PISSN: 15485943     EISSN: 15485951     Source Type: Book Series    
DOI: 10.1146/annurev-clinpsy-032813-153745     Document Type: Review

References (156)

1. Agar-Wilson M, Jackson T. 2012. Are emotion regulation skills related to adjustment among people with chronic pain, independent of pain coping?Eur. J. Pain 16(1):105-14
2. Aggarwal VR, McFarlane GJ, Farragher TM, McBeth J. 2010. Risk factors for onset of chronic oro-facial pain-results of the North Cheshire oro-facial pain prospective population study. Pain 149:354-59
3. Allen LA, Woolfolk RL. 2013. Somatization and conversion disorder. In A CBT Reference Guide, Vol. 2, ed. WRief. New York: Wiley. In press
4. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ. 5th e.d.
5. Bach M, Bach D. 1995. Predictive value of alexithymia: A prospective study in somatizing patients. Psychother. Psychosom. 64:43-48
6. Bailer J, WitthöftM, Rist F. 2008. Psychological predictors of short-And medium-Term outcome in individuals with idiopathic environmental intolerance (IEI) and individuals with somatoform disorders. J. Toxicol. Environ. Health Part A 71:766-75
7. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I. 2002. Imaging how attention modulates pain in humans using functional MRI. Brain 125:310-19
8. Barrett B, Tyrer P, Tyrer H, Cooper S, Crawford MJ, Byford S. 2012. An examination of the factors that influence costs in medical patients with health anxiety. J. Psychosom. Res. 73:59-62
9. Barsky AJ, Ahern DK. 2004. Cognitive behavior therapy for hypochondriasis. A randomized controlled trial. J. Am. Med. Assoc. 291:1464-70
10. Barsky AJ, Orav J, Bates DW. 2005. Somatization increases medical utilization and costs independent of psychiatric and medical morbidity. Arch. Gen. Psychiatry 62:903-10
11. Barsky AJ, Wool C, Barnett MC, Cleary PD. 1994. Histories of childhood trauma in adult hypochondriacal patients. Am. J. Psychiatry 151:397-401
12. Barsky AJ, Wyshak GL. 1990. Hypochondriasis and somatosensory amplification. Br. J. Psychiatry 157:404-9
13. Barsky, AJ, Wyshak G, Klerman GL. 1990. The somatosensory amplification scale and its relationship to hypochondriasis. J. Psychiatr. Res. 24:323-33
14. BernsteinMJ, Claypool HM. 2012. Social exclusion and pain sensitivity: Why exclusion sometimes hurts and sometimes numbs. Personal. Soc. Psychol. Bull. 38:185-96
15. Bogaerts K, Janssens T, De Peuter S, Van Diest I, Van den Bergh O. 2010a. Negative affective pictures can elicit physical symptoms in high habitual symptom reporters. Psychol. Health 25:685-98
16. Bogaerts K, Van Eylen L, Li W, Bresseleers J, Van Diest I, et al. 2010b. Distorted symptom perception in patients with medically unexplained symptoms. J. Abnorm. Psychol. 119:226-34
17. Bogaerts K, Wan L, Diest IV, Stans L, Decramer M, Van den Bergh O. 2012. Peak-end memory bias in laboratory-induced dyspnea: A comparison of patients with medically unexplained symptoms and healthy controls. Psychosom. Med. 74:974-81
18. Bohn D, Bernardy K, Wolfe F, Hauser W. 2013. The association among childhood maltreatment, somatic symptom intensity, depression, and somatoform dissociative symptoms in patients with fibromyalgia syndrome: A single-center cohort study. J. Trauma Dissociation 14:342-58
19. Bradford K, Shih W, Videlock EJ, Presson AP, Naliboff BD, et al. 2012. Association between early adverse life events and irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 10:385-90.e3
20. Brown RJ. 2004. Psychological mechanisms of medically unexplained symptoms: An integrative conceptual model. Psychol. Bull. 130:793-812
21. Brown RJ, Brunt N, Poliakoff E, Lloyd DM. 2010. Illusory touch and tactile perception in somatoform dissociators. J. Psychosom. Res. 69:241-48
22. Brown RJ, Skehan D, Chapman A, Perry EP, McKenzie KJ, et al. 2012. Physical symptom reporting is associated with a tendency to experience somatosensory distortion. Psychosom. Med. 74:648-55
23. Browning M, Fletcher P, Sharpe M. 2011. Can neuroimaging help us to understand and classify somatoform disordersä systematic and critical review. Psychosom. Med. 73:173-84
24. Burton C, Weller D, Sharpe M. 2009. Functional somatic symptoms and psychological states: An electronic diary study. Psychosom. Med. 71:77-78
25. Cella M, White PD, SharpeM, Chalder T. 2013. Cognitions, behaviours and comorbid psychiatric diagnoses in patients with chronic fatigue syndrome. Psychol. Med. 43:375-80
26. Chou R, Shekelle P. 2010. Will this patient develop persistent disabling low back pain?J. Am. Med. Assoc. 303:1295-302
27. Clark DM, Salkovskis PM, Hackman A, Wells A, Fennell M, et al. 1998. Two psychological treatments for hypochondriasis. Br. J. Psychiatry 173:218-25
28. Cloitre M, Miranda R, Stovall-McClough KC, Han H. 2005. Beyond PTSD: Emotion regulation and interpersonal problems as predictors of functional impairment in survivors of childhood abuse. Behav. Ther. 36(2):119-24
29. Colloca L, Benedetti F. 2009. Placebo analgesia induced by social observational learning. Pain 144:28-34
30. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. 2010. How the number of learning trials affects placebo and nocebo responses. Pain 151:430-39
31. Colloca L, Sigaudo M, Benedetti F. 2008. The role of learning in nocebo and placebo effects. Pain 136:211-18
32. Connelly M, Keefe FJ, Affleck G, Lumley MA, Anderson T, Waters S. 2007. Effects of day-To-day affect regulation on the pain experience of patients with rheumatoid arthritis. Pain 131(1-2):162-70
33. Constantinou E, Bogaerts K, Van Diest I, Van den Bergh O. 2013. Inducing symptoms in high symptom reporters via emotional pictures: The interactive effects of valence and arousal. J. Psychosom. Res. 74:191-96
34. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, et al. 2010. Is there a better term than "medically unexplained symptoms"?J. Psychosom. Res. 68:5-8
35. Creed FH, Davies I, Jackson J, Littlewood A, Chew-Graham C, et al. 2012. The epidemiology of multiple somatic symptoms. J. Psychosom. Res. 72:311-17
36. Crichton F, Dodd G, Schmid G, Gamble G, Petrie KJ 2013. Can expectations produce symptoms from infrasound associated with wind turbines?Health Psychol In press
37. Davis KD, Moayedi M. 2013. Central mechanisms of pain revealed through functional and structural MRI. J. Neuroimmune Pharmacol. 8:518-34
38. de Jong JR, Vlaeyen JW, van Eijsden M, Loo C, Onghena P. 2012. Reduction of pain-related fear and increased function and participation in work-related upper extremity pain (WRUEP): Effects of exposure in vivo. Pain 153:2109-18
39. Dimsdale J, Sharma N, Sharpe M 2011. What do physicians think of somatoform disorders?Psychosomatics 52:154-59
40. Dimsdale JE. 2011. Medically unexplained symptoms: A treacherous foundation for somatoform disorders?Psychiatr. Clin. North Am. 34:511-13
41. Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L, et al. 2013. Somatic symptom disorder: An important change in DSM. J. Psychosom. Res. 75:223-28
42. Enck P, Bingel U, Schedlowski M, Rief W. 2013. The placebo response in medicine: Minimize, maximize or personalizeñat. Rev. Drug Discov. 12:191-204
43. Escobar JI, Cook B, Chen C-N, Gara MA, Alegŕia M, et al. 2010. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J. Psychosom. Res. 69:1-8
44. Fink P, Rosendal M, Olesen F. 2005. Classification of somatization and functional somatic symptoms in primary care. Aust. N. Z. J. Psychiatry 39:772-81
45. Fink P, Schröder A. 2010. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J. Psychosom. Res. 68:415-26
46. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. 2007. Symptoms and syndromes of bodily distress: An exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom.Med. 69:30-39
47. Frances A. 2013a. DSM-5 somatic symptom disorder. J. Nerv. Ment. Dis. 201:530-31
48. Frances A. 2013b. Personal view.The new somatic symptom disorder inDSM-5 risksmislabelingmany people as mentally ill. Br. Med. J. 346:f1580
49. Frances AJ, Widiger T. 2012. Psychiatric diagnosis: Lessons from the DSM-IV past and cautions for the DSM-5 future. Annu. Rev. Clin. Psychol. 8:109-30
50. Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ. 2003. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: Association with mood, somatic focus, and catastrophizing. Pain 102:243-50
51. Glombiewski JA, Hartwich-Tersek J, Rief W. 2010a. Two psychological interventions are effective in severely disabled, chronic back pain patients: A randomised controlled trial. Int. J. Behav. Med. 17:97-107
52. Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. 2010b. Psychological treatments for fibromyalgia: A meta-Analysis. Pain 151:280-95
53. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. 2013. Development of fatigue in cancer survivors: A prospective follow-up study from diagnosis into the year after treatment. J. Pain Symptom Manag. 45:213-22
54. Gropalis M, Bleichhardt G, Hiller W, Witthöft M. 2012. Specificity and modifiability of cognitive biases in hypochondriasis. J. Consult. Clin. Psychol. 81(3):1-8
55. Gulec MY, Altintas M, Inanc L, Bezgin CH, Koca EK, Gulec H. 2013. Effects of childhood trauma on somatization in major depressive disorder: The role of alexithymia. J. Affect. Disord. 146:137-41
56. Hadjistavropoulos HD, Hadjistavropoulos T. 2003. The relevance of health anxiety to chronic pain: Research findings and recommendations for assessment and treatment. Curr. Pain Headache Rep. 7:98-104
57. Haukka E, Kaila-Kangas L, Ojajarvi A, Miranda H, Karppinen J, et al. 2013. Pain in multiple sites and sickness absence trajectories: A prospective study among Finns. Pain 154:306-12
58. Hedman E, Andersson G, Andersson E, Ljotsson B, Ruck C, et al. 2011. Internet-based cognitive-behavioural therapy for severe health anxiety: Randomised controlled trial. Br. J. Psychiatry 198(3):230-36
59. Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB. 2008a. The dexamethasone/corticotropinreleasing factor test in men with major depression: Role of childhood trauma. Biol. Psychiatry 63:398-405
60. Heim C, Newport DJ, Mletzko T, Miller AH, Hemeroff CB. 2008b. The link between childhood trauma and depression: Insights from HPA axis studies in humans. Psychoneuroendocrinology 33:693-710
61. Henningsen P, Jakobsen T, Schiltenwolf M, Weiss MG. 2005. Somatization revisited-diagnosis and perceived causes of common mental disorders. J. Nerv. Ment. Dis. 193:85-92
62. Henningsen P, Zipfel S, HerzogW. 2007. Management of functional somatic syndromes. Lancet 369:946-55
63. Hiller W, Cebulla M, Korn HJ, Leibbrand R, Roers B, Nilges P. 2010. Causal symptom attributions in somatoform disorder and chronic pain. J. Psychosom. Res. 68:9-19
64. Hiller W, Rief W, Brähler E. 2006. Somatization in the population: From mild bodily misperceptions to disabling symptoms. Soc. Psychiatry Psychiatr. Epidemiol. 41:704-12
65. HorneR, Faasse K, Cooper V, Diefenbach M A, Leventhal H, et al. 2013. The perceived sensitivity tomedicines (PSM) scale: An evaluation of validity and reliability. Br. J. Health Psychol. 18:18-30
66. Huijbregts KM, Jong FJ, vanMarwijk HW, Beekman AT, Adèr HJ, van der Feltz-Cornelis CM. 2013. A high physical symptom count reduces the effectiveness of treatment for depression, independently of chronic medical conditions. J. Psychosom. Res. 74:179-85
67. Jasper F, Witthöft M. 2013. Automatic evaluative processes in health anxiety and their relations to emotion regulation. Cogn. Ther. Res. 37:521-33
68. Jensen OK, Nielsen CV, Stengaard-Pedersen K. 2010. One-year prognosis in sick-listed low back pain patients with and without radiculopathy. Prognostic factors influencing pain and disability. Spine J. 10:659-75
69. Kahn RS, Skapinakis P, Ahmed K, Stefanou D C, AshraflanH, et al. 2012. The association between preoperative pain, catastrophizing and postoperative pain intensity in cardiac surgery patients. Pain Med. 13:820-27
70. Katzer A, Oberfeld D, Hiller W, Gerlach AL, Witthöft M. 2012. Tactile perceptual processes and their relationship to somatoform disorders. J. Abnorm. Psychol. 121:530-43
71. Katzer A, Oberfeld D, Hiller W, Witthöft M. 2011. Tactile perceptual processes and their relationship to medically unexplained symptoms and health anxiety. J. Psychosom. Res. 71:335-41
72. Kehler MD, Hadjistavropoulos HD. 2009. Is health anxiety a significant problem for individuals with multiple sclerosis?J. Behav. Med. 32:150-61
73. Keijsers E, Feleus A, Miedema HS, Koes BW, Bierma-Zeinstra SM. 2010. Psychosocial factors predicted nonrecovery in both specific and nonspecific diagnoses at arm, neck, and shoulder. J. Clin. Epidemiol. 63:1370-79
74. Kirmayer LJ, Taillefer S. 1997. Somatoform disorders. In Adult Psychopathology and Diagnosis, ed. SM Turner, M Hersen, pp. 333-83. New York: Wiley
75. Klaus K, Rief W, Brahler E, Martin A, Glaesmer H, Mewes R. 2013. The distinction between "medically unexplained" and "medically explained" in the context of somatoform disorders. Int. J. Behav. Med. 20:161-71
76. Kleinstäuber M, Witthöft M, Hiller W. 2011. Efficacy of short-Term psychotherapy for multiple medically unexplained physical symptoms: A meta-Analysis. Clin. Psychol. Rev. 31:146-60
77. Kohl A, Rief W, Glombiewski JA. 2013. Acceptance, cognitive restructuring, and distraction as coping strategies for acute pain. J. Pain 14:305-15
78. KonnopkaA, Schaefert R, Heinrich S, Kaufmann C, Luppa M, et al. 2012. Economics of medically unexplained symptoms: A systematic review of the literature. Psychother. Psychosom. 81:265-75
79. Kotov R, Ruggero CJ, Krueger RF, Watson D, Yuan QL, Zimmerman M. 2011. New dimensions in the quantitative classification of mental illness. Arch. Gen. Psychiatry 68:1003-11
80. Kupfer DJ, Kuhl EA, Regier DA. 2013. DSM-5-The future arrived. J. Am. Med. Assoc. 309:1691-92
81. Kuwert P, Braehler E, Freyberger HJ, Glaesmer H. 2012. More than 60 years later: The mediating role of trauma and posttraumatic stress disorder for the association of forced displacement in WorldWar II with somatization in old age. J. Nerv. Ment. Dis. 200:911-14
82. Lacourt T, Houtveen J, van Doornen L. 2013. "Functional somatic syndromes, one or many?": An answer by cluster analysis. J. Psychosom. Res. 74:6-11
83. Landa A, Peterson BS, Fallon BA. 2012. Somatoform pain: A developmental theory and translational research review. Psychosom. Med. 74:717-27
84. Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. 2007. The fear-Avoidance model of musculoskeletal pain: Current state of scientific evidence. J. Behav. Med. 30:77-94
85. Levenson JL. 2011. The somatoform disorders: 6 characters in search of an author. Psychiatr. Clin. North Am. 34:515-24
86. Lim SL, Kim JH. 2005. Cognitive processing of emotional information in depression, panic, and somatoform disorder. J. Abnorm. Psychol. 114:50-61
87. Lloyd DM, Mason L, Brown RJ, Poliakoff E. 2008. Development of a paradigm for measuring somatic disturbance in clinical populations with medically unexplained symptoms. J. Psychosom. Res. 64:21-24
88. Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. 2008. Depression, anxiety and somatization in primary care: Syndrome overlap and functional impairment. Gen. Hosp. Psychiatry 30:191-99
89. Lukkahatai N, Saligan LN. 2013. Association of catastrophizing and fatigue: A systematic review. J. Psychosom. Res. 74:100-9
90. Marcus DK, Gurley JR, Marchi MM, Bauer C. 2007. Cognitive and perceptual variables in hypochondriasis and health anxiety: A systematic review. Clin. Psychol. Rev. 27:127-39
91. Martin A, Buech A, Schwenk C, Rief W. 2007. Memory bias for health related information in somatoform disorders. J. Psychosom. Res. 63:663-71
92. Martin A, Jacobi F. 2006. Features of hypochondriasis and illness worry in the general population inGermany. Psychosom. Med. 68:770-77
93. Martin A, Rief W. 2011. Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders. Psychiatr. Clin. North Am. 34:565-78
94. McKenzie M, Clarke DM, McKenzie DP, Smith GC. 2010. Which factors predict the persistence of DSM-IV depression, anxiety, and somatoform disorders in the medically ill three months post hospital discharge?J. Psychosom. Res. 68:21-28
95. McWilliams LA, Bailey SJ. 2010. Associations between adult attachment ratings and health conditions: Evidence from the National Comorbidity Survey Replication. Health Psychol. 29:446-53
96. Miles E, Poliakoff E, Brown RJ. 2011. Medically unexplained symptom reports are associated with a decreased response to the rubber hand illusion. J. Psychosom. Res. 71:240-44
97. Morley S. 2011. Efficacy and effectiveness of cognitive behaviour therapy for chronic pain: Progress and some challenges. Pain 152:S99-106
98. Nelson S, Baldwin N, Taylor J. 2012. Mental health problems and medically unexplained physical symptoms in adult survivors of childhood sexual abuse: An integrative literature review. J. Psychiatr. Ment. Health Nurs. 19:211-20
99. Nijs J, Rousse lN, Van Oosterwijck J, De KooningM, Ickmans K, et al. 2013. Fear of movement and avoidance behaviour toward physical activity in chronic-fatigue syndrome and fibromyalgia: State of the art and implications for clinical practice. Clin. Rheumatol. 32:1121-29
100. Nikendei C, Waldherr S, Schiltenwolf M, Herzog W, Rohrig M, et al. 2009. Memory performance related toorganic and psychosocial illness attributions in somatoform pain disorder patients. J. Psychosom. Res. 67:199-206
101. OftedalG, Straume A, Johnsson A, Stovner LJ. 2007. Mobile phone headache: A double blind, sham-controlled provocation study. Cephalalgia 27:447-55
102. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B, et al. 2012. The economic cost of brain disorders in Europe. Eur. J. Neurol. 19:155-62
103. Pennebaker JW. 1982. The Psychology of Physical Symptoms. New York: Springer
104. Pincus T, Morley S. 2001. Cognitive-processing bias in chronic pain: A review and integration. Psychol. Bull. 127:599-61
105. Posserud I, Svedlund J, Wallin J, Simren M. 2009. Hypervigilance in irritable bowel syndrome compared withorganic gastrointestinal disease. J. Psychosom. Res. 66:399-405
106. Quartana PJ, Campbell CM, Edwards RR. 2009. Pain catastrophizing: A critical review. Expert Rev. Neurother. 9:745-58
107. Raspe H, Hueppe A, Neuhauser H. 2008. Back pain, a communicable disease. Int. J. Epidemiol. 37:69-74
108. Regier DA, NarrowWE, Clarke DE, Kraemer HC, Kuramoto SJ, et al. 2013. DSM-5 field trials in theUnited States andCanada, part II: Test-retest reliability of selected categorical diagnoses. Am. J. Psychiatry 170:59-70
109. Riebel K, Egloff B, Witthöft M. 2013. The implicit health-related self-concept in somatoform disorders. J. Behav. Therapy Exp. Psychiatry 44:335-42
110. Rief W, Avorn J, Barsky AJ. 2006a. Medication-Attributed adverse effects in placebo groups. Implications for assessment of adverse effects. Arch. Intern. Med. 166:155-60
111. Rief W, Barsky AJ. 2005. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 30:996-1002
112. Rief W, Bingel U, Schedlowski M, Enck P. 2011a. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin. Pharmacol. Ther. 90:722-26
113. Rief W, Broadbent E. 2007. Explaining medically unexplained symptoms: Models and mechanisms. Clin. Psychol. Rev. 27:821-41
114. Rief W, Heitmüller AM, Reisberg K, Rüddel H. 2006b. Why reassurance fails in patients with unexplained symptoms-An experimental investigation of remembered probabilities. PLoS Med. 3:e269
115. Rief W, Hennings A, Riemer S, Euteneuer F. 2010a. Psychobiological differences between depression and somatization. J. Psychosom. Res. 68:495-502
116. Rief W, Hessel A, Braehler E. 2001. Somatization symptoms and hypochondriacal features in the general population. Psychosom. Med. 63:595-602
117. Rief W, Heuser J, Fichter MM. 1996. What does the Toronto Alexithymia Scale TAS-R measure?J. Clin. Psychol. 52:423-29
118. Rief W, Isaac M. 2007. Are somatoform disorders "mental disorders"ä contribution to the current debate. Curr. Opin. Psychiatry 20:143-46
119. Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. 2010b. Are psychological features useful in classifying patients with somatic symptoms?Psychosom. Med. 72:648-55
120. Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. 2011b. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosom. Med. 73:760-68
121. Rief W, Nanke A, Emmerich J, Bender A, Zech T. 2004. Causal illness attributions in somatoform disorders: Associations with comorbidity and illness behavior. J. Psychosom. Res. 57:367-71
122. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, et al. 2009. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: A systematic review and metaanalysis. Drug Saf. 32:1041-56
123. Rief W, Rojas G. 2007. Stability of somatoform symptoms: Implications for classification. Psychosom. Med. 69:864-69
124. Rosmalen JGM, Tak LM, de Jonge P. 2011. Empirical foundations for the diagnosis of somatization: Implications for DSM-5. Psychol. Med. 41:1133-42
125. Ruchkin V, Schwab-Stone M. 2013. A longitudinal study of somatic complaints in urban adolescents: The role of internalizing psychopathology and somatic anxiety. J. Youth Adolesc. In press
126. Salkovskis PM. 1995. Effective Treatment of Severe Health Anxiety (Hypochondriasis). Copenhagen: World Congress Behav. Cogn. Ther
127. Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J, et al. 2012. Brief psychodynamic-interpersonal psychotherapy for patients with multisomatoform disorder: A randomised controlled trial. Br. J. Psychiatry 100:60-67
128. Schaefer M, Egloff B, Witthöft M. 2012. Is interoceptive awareness really altered in somatoform disorders?Testing competing theories with two paradigms of heartbeat perception. J. Abnorm. Psychol. 121:719-24
129. Scholz B, Ott R, Sarnoch H. 2001. Proprioception in somatoform disorders. Behav. Res. Ther. 39:1429-38
130. Schroder A, Rehfeld E, Ornbol E, Sharpe M, Licht RW, Fink P. 2012. Cognitive-behavioural group treatment for a range of functional somatic syndromes: Randomised trial. Br. J. Psychiatry 200:499-507
131. Schweinhardt P, Kalk N, Wartolowska K, Chessell I, Wordsworth P, Tracey I. 2008. Investigation into the neural correlates of emotional augmentation of clinical pain. NeuroImage 40:759-66
132. Seminovicz DA, Davis KD. 2006. Cortical responses to pain in healthy individuals depends on pain catastrophizing. Pain 120:297-306
133. Sørensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. 2010. A randomized clinical trial of cognitive behavioural therapy versus short-Term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol. Med. 41:431-41
134. SteinMB, Barrett-Connor E. 2000. Sexual assault and physical health: Findings from a population-based study of older adults. Psychosom. Med. 62:838-43
135. Steinbrecher N, Koerber S, Frieser D, Hiller W. 2011. The prevalence of medically unexplained symptoms in primary care. Psychosomatics 52:263-71
136. Taylor GJ, Bagby RM, Parker JDA. 1992. The revised Toronto Alexithymia Scale: Some reliability, validity, and normative data. Psychother. Psychosom. 57:34-41
137. Taylor RE, Mann AH, WhiteNJ, Goldberg DP. 2000. Attachment style in patients with unexplained physical complaints. Psychol. Med. 30:931-41
138. Taylor RE, Marshall T, Mann A, Goldberg DP. 2012. Insecure attachment and frequent attendance in primary care: A longitudinal cohort study of medically unexplained symptom presentations in ten UK general practices. Psychol. Med. 42:855-64
139. Tomenson B, Creed F, DSM-5 Population Project Group. 2010. Can we diagnose somatoform disorders using all bodily symptoms rather than "medically unexplained" symptoms?J. Psychosom. Res. 68:670
140. Tomenson B, Essau C, Jacobi F, Ladwig KH, Leiknes KA, et al. 2013. Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br. J. Psychiatry 203:373-80
141. Tomenson B, McBeth J, Chew-Graham CA, MacFarlane G, Davies I, et al. 2012. Somatization and health anxiety as predictors of health care use. Psychosom. Med. 74:656-64
142. Tyrer P, Cooper S, Crawford M, Dupont S, Green J, et al. 2011. Prevalence of health anxiety problems in medical clinics. J. Psychosom. Res. 71:392-94
143. Vernia P, Di Camillo M, Foglietta T, Avallone VE, De Carolis A. 2013. Diagnosis of lactose intolerance and the "nocebo" effect: The role of negative expectations. Dig. Liver Dis. 42:616-19
144. Vlaeyen JWS, Linton SJ. 2000. Fear-Avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 85:317-32
145. Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Löwe B. 2010. Towards positive diagnostic criteria: A systematic review of somatoform disorder diagnoses and suggestions for future classification. J. Psychosom. Res. 68:403-14
146. Voigt K, Wollburg E, Weinmann N, Herzog A, Meyer B, et al. 2012. Predictive validity and clinical utility of DSM-5 somatic symptom disorder-comparison with DSM-IV somatoform disorders and additional criteria for consideration. J. Psychosom. Res. 73:345-50
147. Wade JB, Riddle DL, Price DD, Dumenci L. 2011. Role of pain catastrophizing during pain processing in a cohort of patients with chronic and severe arthritic knee pain. Pain 152:314-19
148. Warren JW, Clauw DJ. 2012. Functional somatic syndromes: Sensitivities and specificities of self-reports of physician diagnosis. Psychosom. Med. 74:891-95
149. Warren JW, Langenberg P, Clauw DJ. 2013. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J. Psychosom. Res. 74:12-17
150. Watson D, Pennebaker JW. 1989. Health complaints, stress, and distress: Exploring the central role of negative affectivity. Psychol. Rev. 96:234-54
151. Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA, et al. 2011. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain 152:2098-107
152. White PD. 2013. Functional somatic syndromes may be either "polysyndromic" or "monosyndromic." J. Psychosom. Res. 74:2-3
153. Wingenfeld K, Terfehr K, Meyer B, Löwe B, Spitzer C. 2013. Memory bias for emotional and illness-related words in patients with depression, anxiety and somatization disorders: An investigation with the directed forgetting task. Psychopathology 46:22-27
154. Witthöft M, Hiller W. 2010. Psychological approaches to origins and treatments of somatoform disorders. Annu. Rev. Clin. Psychol. 6:257-83
155. WitthöftM, Rubin GJ. 2013. Aremedia warnings about the adverse health effects of modern life self-fulfillingän experimental study on idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF). J. Psychosom. Res. 74:206-12
156. Wollburg E, Voigt K, Braukhaus C, Herzog A, Lowe B. 2013. Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5. J. Psychosom. Res. 74:18-24.